phosphoramidic acid has been researched along with guanosine monophosphate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aljarah, M; Ames, B; Brancale, A; Chamberlain, S; Ganguly, B; Gilles, A; Gorovits, E; Hall, A; Henson, G; Hutchins, J; Kolykhalov, A; Madela, K; McGuigan, C; Muhammad, J; Patti, JM; Vernachio, J; Wang, J; Zonta, N | 1 |
| Aljarah, M; Battina, SK; Chamberlain, S; Gilles, A; Hall, A; Henson, G; Hutchins, J; Kolykhalov, A; Madela, K; McGuigan, C; Ramamurty, CV; Srinivas Rao, C; Vernachio, J | 1 |
2 other study(ies) available for phosphoramidic acid and guanosine monophosphate
| Article | Year |
|---|---|
Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus.
Topics: Amides; Antiviral Agents; Cells, Cultured; Drug Design; Guanosine; Guanosine Monophosphate; Hepacivirus; Humans; Phosphoric Acids; Prodrugs | 2010 |
Dual pro-drugs of 2'-C-methyl guanosine monophosphate as potent and selective inhibitors of hepatitis C virus.
Topics: Amides; AMP Deaminase; Antiviral Agents; Cell Line, Tumor; Drug Design; Drug Evaluation, Preclinical; Guanosine Monophosphate; Hepacivirus; Hepatitis C; Humans; Hydrolysis; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Nucleosides; Phosphoric Acids; Phosphorylation; Prodrugs; Stereoisomerism; Structure-Activity Relationship; Virus Replication | 2011 |